<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.02">
 <iati-activity default-currency="EUR" hierarchy="1" humanitarian="0" iati-activities:version="2.02" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>NL-KVK-34185938-ATMI-FY18</iati-identifier>
  <reporting-org ref="NL-KVK-34185938" type="60">
   <narrative xml:lang="EN">Access to Medicine Foundation</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">Access to Medicine Index FY18</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="EN">The Access to Medicine Index analyses 20 of the world&#xE2;&#x20AC;&#x2122;s largest research-based pharmaceutical companies on how they make medicines, vaccines and diagnostics more accessible in low- and middle-income countries. This activity files includes the 2018 activities.</narrative>
  </description>
  <participating-org ref="XM-DAC-DAC-1601" role="1" type="60">
   <narrative xml:lang="EN">Bill and Melinda Gates Foundation</narrative>
  </participating-org>
  <participating-org ref="XM-DAC-7" role="1" type="10">
   <narrative xml:lang="EN">Netherlands - Ministry of Foreign Affairs</narrative>
  </participating-org>
  <participating-org ref="GB-GOV-1" role="1" type="10">
   <narrative xml:lang="EN">UK - Department for International Development (DFID)</narrative>
  </participating-org>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2018-01-01" type="2"></activity-date>
  <activity-date iso-date="2018-12-31" type="3"></activity-date>
  <recipient-country code="NL" percentage="100">
   <narrative xml:lang="EN">The 2018 Access to Medicine Index will measure pharmaceutical companies&apos; efforts to improve access to medicine across 106 low- and middle-income countries. The Access to Medicine Index team is based in The Netherlands.</narrative>
  </recipient-country>
  <sector code="12220" percentage="100" vocabulary="1"></sector>
  <budget status="2" type="1">
   <period-start iso-date="2018-01-01"></period-start>
   <period-end iso-date="2018-12-31"></period-end>
   <value currency="EUR" value-date="2018-01-01">2218545</value>
  </budget>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2018-01-01"></transaction-date>
   <value currency="EUR" value-date="2018-01-01">2218545</value>
   <description>
    <narrative xml:lang="EN">ATMF commitment to spend on ATMI</narrative>
   </description>
  </transaction>
  <transaction>
   <transaction-type code="1"></transaction-type>
   <transaction-date iso-date="2018-01-01"></transaction-date>
   <value currency="USD" value-date="2018-01-01">481617</value>
   <description>
    <narrative xml:lang="EN">Deferred income from BMGF</narrative>
   </description>
  </transaction>
  <transaction>
   <transaction-type code="1"></transaction-type>
   <transaction-date iso-date="2018-01-01"></transaction-date>
   <value currency="GBP" value-date="2018-01-01">348564</value>
   <description>
    <narrative xml:lang="EN">Deffered income from DFID</narrative>
   </description>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2018-09-30"></transaction-date>
   <value currency="EUR" value-date="2018-09-30">1109358</value>
   <description>
    <narrative xml:lang="EN">Employee, depreciation, travel, financial, housing, consultants and supply expenses for the period 1 Jan 2018 - 30 Sept 2018.</narrative>
   </description>
  </transaction>
  <transaction>
   <transaction-type code="1"></transaction-type>
   <transaction-date iso-date="2018-03-12"></transaction-date>
   <value currency="GBP" value-date="2018-03-12">287500</value>
   <description>
    <narrative xml:lang="EN">Incoming Funds from DFID</narrative>
   </description>
   <provider-org ref="GB-GOV-1" type="10">
    <narrative xml:lang="EN">UK Department for International Development (DFID)</narrative>
   </provider-org>
  </transaction>
  <transaction>
   <transaction-type code="1"></transaction-type>
   <transaction-date iso-date="2018-12-07"></transaction-date>
   <value currency="GBP" value-date="2018-12-07">287500</value>
   <description>
    <narrative xml:lang="EN">Incoming Funds from DFID</narrative>
   </description>
   <provider-org ref="GB-GOV-1" type="10"></provider-org>
  </transaction>
  <transaction>
   <transaction-type code="11"></transaction-type>
   <transaction-date iso-date="2018-04-01"></transaction-date>
   <value currency="EUR" value-date="2018-04-01">575000</value>
   <description>
    <narrative xml:lang="EN">Incoming commitment from Minbuza</narrative>
   </description>
   <provider-org provider-activity-id="XM-DAC-7-PPR-4000001257" ref="XM-DAC-7" type="10">
    <narrative xml:lang="EN">Dutch Ministry of Foreign Affairs</narrative>
   </provider-org>
  </transaction>
  <transaction>
   <transaction-type code="1"></transaction-type>
   <transaction-date iso-date="2018-07-06"></transaction-date>
   <value currency="USD" value-date="2018-07-06">381950</value>
   <description>
    <narrative xml:lang="EN">Incoming funds from BMGF</narrative>
   </description>
   <provider-org ref="XM-DAC-DAC-1601" type="60">
    <narrative xml:lang="EN">Bill and Melinda Gates Foundation</narrative>
   </provider-org>
  </transaction>
  <transaction>
   <transaction-type code="1"></transaction-type>
   <transaction-date iso-date="2018-04-06"></transaction-date>
   <value currency="EUR" value-date="2018-04-06">575000</value>
   <description>
    <narrative xml:lang="EN">Incoming funds from Minbuza</narrative>
   </description>
   <provider-org provider-activity-id="XM-DAC-7-PPR-4000001257" ref="XM-DAC-7">
    <narrative xml:lang="EN">Dutch Ministry of Foreign Affairs</narrative>
   </provider-org>
  </transaction>
  <transaction>
   <transaction-type code="11"></transaction-type>
   <transaction-date iso-date="2017-06-20"></transaction-date>
   <value currency="USD" value-date="2018-01-01">863567</value>
   <description>
    <narrative xml:lang="EN">Part of the grant agreement with BMGF allocated to FY2018</narrative>
   </description>
   <provider-org ref="XM-DAC-DAC-1601" type="60">
    <narrative xml:lang="EN">Bill and Melinda Gates Foundation</narrative>
   </provider-org>
  </transaction>
  <transaction>
   <transaction-type code="11"></transaction-type>
   <transaction-date iso-date="2016-09-30"></transaction-date>
   <value currency="GBP" value-date="2018-01-01">806324</value>
   <description>
    <narrative xml:lang="EN">Part of the grant agreement with UK-DFID allocated to FY2018</narrative>
   </description>
   <provider-org ref="GB-GOV-1" type="10">
    <narrative xml:lang="EN">UK-Department for International Development</narrative>
   </provider-org>
  </transaction>
  <document-link format="APPLICATION/PDF" url="https://accesstomedicinefoundation.org/media/atmf/2017-Methodology-Report-for-2018-Access-to-Medicine-Index.pdf">
   <title>
    <narrative xml:lang="EN">Methodology Report for the 2018 Access to Medicine Index</narrative>
   </title>
   <category code="A02"></category>
   <language code="EN"></language>
   <document-date iso-date="2017-10-05"></document-date>
  </document-link>
  <document-link format="APPLICATION/HTTP" url="https://accesstomedicinefoundation.org/publications/2018-access-to-medicine-index">
   <title>
    <narrative xml:lang="EN">2018 Access to Medicine Index</narrative>
   </title>
   <category code="A02"></category>
   <document-date iso-date="2018-11-20"></document-date>
  </document-link>
  <result aggregation-status="0" type="1">
   <title>
    <narrative xml:lang="EN">2018 Access to Medicine Index report</narrative>
   </title>
   <indicator measure="1">
    <title>
     <narrative xml:lang="EN">Publication of 2018 Access to Medicine Index report</narrative>
    </title>
    <reference code="Not availalbe" indicator-uri="https://accesstomedicinefoundation.org/publications/2018-access-to-medicine-index" vocabulary="99"></reference>
    <baseline value="0" year="2017">
     <comment>
      <narrative xml:lang="EN">The production cycle for the 2018 Access to Medicine Index started in 2017.</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2017-01-01"></period-start>
     <period-end iso-date="2018-12-31"></period-end>
     <target value="1"></target>
     <actual value="1">
      <comment>
       <narrative xml:lang="EN">The 2018 Access to Medicine Index has been published in November 2018.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="2">
   <title>
    <narrative xml:lang="EN">Improvements by pharmaceutical companies on policies and practices related to access to medicine</narrative>
   </title>
   <indicator measure="1">
    <title>
     <narrative xml:lang="EN">Examples of progress by companies in each ATM Index technical area</narrative>
    </title>
    <baseline value="0" year="2017"></baseline>
    <period>
     <period-start iso-date="2016-07-01"></period-start>
     <period-end iso-date="2018-12-31"></period-end>
     <target value="3">
      <comment>
       <narrative xml:lang="EN">For the 2018 Index, the time period for which data will be analysed covers company activities which must be ongoing between June 2016 and the end of May 2018, as this the cycle of the Index. Results will be published in Q4 2018.</narrative>
      </comment>
     </target>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">Investor-company launches of the 2018 Access to Medicine Index</narrative>
   </title>
   <indicator measure="1">
    <title>
     <narrative xml:lang="EN">Organisation of investor-company launches of the 2018 Access to Medicine Index</narrative>
    </title>
    <baseline value="0" year="2018"></baseline>
    <period>
     <period-start iso-date="2018-10-01"></period-start>
     <period-end iso-date="2018-12-31"></period-end>
     <target value="3">
      <comment>
       <narrative xml:lang="EN">The target is to organise three events: in London with European pharmaceutical companies, in NYC with US pharmaceutical companies and in Tokyo with Japanese pharmaceutical companies.</narrative>
      </comment>
     </target>
     <actual value="3"></actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">Top media coverage of the 2018 Access to Medicine Index</narrative>
   </title>
   <indicator measure="1">
    <title>
     <narrative xml:lang="EN">Number of top media outlets (including Dutch media outlets) covering the 2018 Access to Medicine Index</narrative>
    </title>
    <baseline value="0" year="2018"></baseline>
    <period>
     <period-start iso-date="2018-11-01"></period-start>
     <period-end iso-date="2018-12-31"></period-end>
     <target value="5">
      <comment>
       <narrative xml:lang="EN">Targets include medial outlets like NRC, Guardian, Reuters, Financial Times and New York Times.</narrative>
      </comment>
     </target>
     <actual value="8"></actual>
    </period>
   </indicator>
  </result>
 </iati-activity>
</iati-activities>
